Abstract
Isolated central nervous system (CNS) relapse of non-seminomatous germ cell tumour (NSGCT) of the testis has been reported in only 12 patients previously. We report a patient with an isolated CNS relapse of NSGCT, following a prior systemic relapse. From a review of previous cases, isolated CNS relapse appears to be more common in patients with embryonal cell histology (alone or mixed with other elements) and occurred after a median of 8.5 months following initial presentation. Long-term survival appears possible using multi-modal treatment with whole-brain radiotherapy, surgery and/or chemotherapy. However, the optimal treatment of isolated CNS relapse remains undefined.
Copyright 2001 S. Karger AG, Basel
MeSH terms
-
Adult
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Biomarkers, Tumor / analysis
-
Brain Neoplasms / radiotherapy
-
Brain Neoplasms / secondary*
-
Brain Neoplasms / surgery
-
Carcinoma, Embryonal / drug therapy
-
Carcinoma, Embryonal / radiotherapy
-
Carcinoma, Embryonal / secondary*
-
Carcinoma, Embryonal / surgery
-
Cisplatin / administration & dosage
-
Combined Modality Therapy
-
Cranial Irradiation
-
Etoposide / administration & dosage
-
Humans
-
Lung Neoplasms / drug therapy
-
Lung Neoplasms / secondary
-
Lymphatic Metastasis
-
Male
-
Occipital Lobe* / surgery
-
Orchiectomy
-
Radiotherapy, Adjuvant
-
Remission Induction
-
Testicular Neoplasms / pathology*
-
Testicular Neoplasms / surgery
-
Tomography, X-Ray Computed
-
Vision Disorders / etiology
-
alpha-Fetoproteins / analysis
Substances
-
Biomarkers, Tumor
-
alpha-Fetoproteins
-
Etoposide
-
Cisplatin